Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide in Active Lymphocytic Colitis
NCT00217022Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2003
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in Lymphocytic Colitis (LC), sponsored by Mayo Clinic. Started Jun 2003; status: terminated.
02
Drugs
budesonide
03
Conditions
Lymphocytic Colitis (LC)
Beyond the preview
Go deeper on NCT00217022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217022.